Budesonide and Metamorphopsia - a phase IV clinical study of FDA data

Summary:

Metamorphopsia is reported as a side effect among people who take Budesonide (budesonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Atrovent, and have High blood pressure.

The phase IV clinical study analyzes which people have Metamorphopsia when taking Budesonide. It is created by eHealthMe based on reports of 42,490 people who have side effects when taking Budesonide from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Metamorphopsia?

Metamorphopsia (a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank) is found to be associated with 212 drugs and 367 conditions by eHealthMe. Check the latest studies of Metamorphopsia.

On Jul, 17, 2026

42,490 people reported to have side effects when taking Budesonide.
Among them, 31 people (0.07%) have Metamorphopsia.

Among these 31 people:

How long have people been on Budesonide when they have Metamorphopsia? *

What is the gender of people who have Metamorphopsia when taking Budesonide? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Metamorphopsia when taking Budesonide? *

What are other drugs people take besides Budesonide? *

What are other side effects people have besides Metamorphopsia? *

Abdominal Discomfort: 25 people, 80.65%
Photopsia (presence of perceived flashes of light): 25 people, 80.65%
Eye Pain: 25 people, 80.65%
Foreign Body Sensation In Eyes (feeling of something in eye): 25 people, 80.65%
Vitreous Floaters (spots before the eyes): 25 people, 80.65%
Optic Nerve Disorder (disease of optic nerve): 3 people, 9.68%
Hypotension (abnormally low blood pressure): 3 people, 9.68%
Visual Field Defect: 3 people, 9.68%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.45%
Optic Atrophy (the loss of a proportion of optic disc nerve fibres): 2 people, 6.45%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 3 people, 9.68%
High Blood Pressure: 3 people, 9.68%
Insomnia (sleeplessness): 1 person, 3.23%
Blood Folate Decreased: 1 person, 3.23%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 3.23%
Fever: 1 person, 3.23%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 3.23%
Hiv Infection: 1 person, 3.23%
Superinfection: 1 person, 3.23%
Respiratory Muscle Weakness: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and have Metamorphopsia?

- Check whether Metamorphopsia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Budesonide:

Budesonide (42,933 reports)

Metamorphopsia treatments and more:

Metamorphopsia (2,072 reports)

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metamorphopsia:

Metamorphopsia (212 drugs)

Browse all the conditions that are associated with Metamorphopsia:

Metamorphopsia (367 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Budesonide) and Budesonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.